-
Signature
-
By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik
-
Stock symbol
-
LHX
-
Transactions as of
-
Mar 25, 2024
-
Transactions value $
-
-$5,316,805
-
Form type
-
4
-
Date filed
-
3/27/2024, 04:36 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LHX |
Common Stock, Par Value $1.00 |
Options Exercise |
$3.89M |
+40K |
+34.43% |
$97.24 |
156K |
Mar 25, 2024 |
Direct |
|
transaction |
LHX |
Common Stock, Par Value $1.00 |
Sale |
-$8.49M |
-40K |
-25.61% |
$212.22 |
116K |
Mar 25, 2024 |
Direct |
F1 |
transaction |
LHX |
Common Stock, Par Value $1.00 |
Options Exercise |
$609K |
+6.26K |
+5.39% |
$97.24 |
122K |
Mar 26, 2024 |
Direct |
|
transaction |
LHX |
Common Stock, Par Value $1.00 |
Sale |
-$1.33M |
-6.26K |
-5.11% |
$211.91 |
116K |
Mar 26, 2024 |
Direct |
|
holding |
LHX |
Common Stock, Par Value $1.00 |
|
|
|
|
|
43K |
Mar 25, 2024 |
By grantor retained annuity trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LHX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-40K |
-86.47% |
$0.00 |
6.26K |
Mar 25, 2024 |
Common Stock, Par Value $1.00 |
40K |
$97.24 |
Direct |
|
transaction |
LHX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-6.26K |
-100% |
$0.00* |
0 |
Mar 26, 2024 |
Common Stock, Par Value $1.00 |
6.26K |
$97.24 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: